Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients

Hina Sahi1, Robin K Avery, Omar A Minai

  • 1Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic, Cleveland, Ohio 44195, USA.

Abstract

Insights

Scedosporium apiospermum is a dangerous fungus in lung transplant patients, often spreading and leading to poor outcomes. Early diagnosis and combination antifungal therapy are crucial for improving prognosis.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Transplant Medicine

Background:

  • Scedosporium apiospermum, the asexual form of Pseudallescheria boydii, is an emerging opportunistic pathogen.
  • Infections in transplant recipients are linked to high dissemination rates and adverse outcomes.

Observation:

  • A retrospective analysis identified five lung transplant recipients with S. apiospermum isolated from respiratory samples.
  • Three patients developed disseminated disease, while two showed only colonization.

Findings:

  • Scedosporium apiospermum poses a significant risk in lung transplant recipients.
  • The fungus exhibits inherent resistance to amphotericin B, necessitating alternative treatment strategies.

Implications:

  • Early and accurate diagnosis, differentiating Scedosporium from Aspergillus, is critical.
  • Combination antifungal therapies, surgical intervention, and expedited immune recovery are vital for improved patient prognosis.
  • Close clinical monitoring and treatment reevaluation are essential for managing Scedosporium infections.